Table of Services

Biostatistics and Bioinformatics Facility Publications

2012

  • Arrangoiz R, Papavasiliou P, Stransky CA, Yu JQ, Li T, Sigurdson ER, Berger AC, Farma JM. Preoperative FDG-PET/CT is an important tool in the management of patients with thick (T4) melanoma. Dermatol Res Pract. 2012; 2012:614349.
  • Bradbury AR, Patrick-Miller L, Egleston B, Olopade OI, Daly M, Moore CW, Sands CB, Schmidheiser H, Kondaumudi PK, Feigon M, Ibe CN, Daugherty CK. When parents disclose BRCA1/2 test results: Their communication and perceptions of offspring response. Cancer 2011; 118(13):3417-25.
  • Canter D, Egleston B, Wong YN, Smaldone MC, Simhan J, Greenberg RE, Uzzo RG, Kutikov A. Use of radical cystectomy as initial therapy for the treatment of high-grade T1 urothelial carcinoma of the bladder: A SEER database analysis. Urol Oncol. Forthcoming 2012.
  • Cauchi C, Somaiah N, Engstrom PF, Litwin S, Lopez M, Lee J, Davey M, Bove B, von Mehren M. Evaluation of nilotinib in advanced GIST previously treated with imatinib and sunitinib. Cancer Chemother Pharmacol. 2011; 69(4):977-82.
  • Cook RL, Zhu F, Belnap BH, Weber KM, Cole SR, Vlahov D, Cook JA, Hessol NA, Wilson TE, Plankey M, Howard AA, Sharp GB, Richardson JL, Cohen MH. Alcohol consumption trajectory patterns in adult women with HIV infection AIDS Behav. Forthcoming 2012.
  • Crivello ML, Ruth K, Sigurdson ER, Egleston BL, Evers K, Wong YN, Boraas M, Bleicher RJ. Advanced imaging modalities in early stage breast cancer: Preoperative use in the United States Medicare Population. Ann Surg Oncol. 2011; 60(2):241-48.
  • Dorgan JF, Klifa C, Shepherd JA, Egleston BL, Kwiterovich PO Jr, Himes JH, Gabriel KP, Van Horn L, Snetselaar LG, Stevens VJ, Barton BA, Robson AM, Lasser NL, Deshmukh S, Hylton NM. Height adiposity and body fat distribution and breast density in young women. Breast Cancer Res. 2012; 14(4):R107.
  • Doss M, Egleston BL, Litwin S. Comments on "Studies of the Mortality of Atomic Bomb Survivors Report 14 1950-2003: An Overview of Cancer and Noncancer Diseases" (Radiat Res 2012; 177:229-43) Radiat Res. Forthcoming 2012.
  • Dotan E, Meropol NJ, Burtness B, Denlinger CS, Lee J, Mintzer D, Zhu F, Ruth K, Tuttle H, Sylvester J, Cohen SJ. A phase II study of capecitabine oxaliplatin and cetuximab with or without bevacizumab as frontline therapy for metastatic colorectal cancer A Fox Chase extramural research study. J Gastrointest Cancer. Forthcoming 2012.
  • Dotan E, Meropol NJ, Zhu F, Zambito F, Bove B, Cai KQ, Godwin AK, Golemis EA, Astsaturov I, Cohen SJ. Relationship of increased aurora kinase A gene copy number prognosis and response to chemotherapy in patients with metastatic colorectal cancer. Br J Cancer. 2012; 106(4):748-55.
  • Egleston BL. Response to Pearl's comments on principal stratification Int J Biostat. 2012; 7(1):24.
  • Fang CY, Egleston BL, Gabriel KP, Stevens VJ, Kwiterovich PO Jr, Snetselaar LG, Longacre ML, Dorgan JF. Depressive symptoms and serum lipid levels in young adult women. J Behav Med. Forthcoming 2012.
  • Fleisher L, Kandadai V, Keenan E, Miller SM, Devarajan K, Ruth K, Rodeletz M, Bieber EJ, Weinberg DS. Build it and will they come? Unexpected findings from a study on a web-based intervention to improve colorectal cancer screening. J Health Commun, 2012; 17:41-53.
  • Freedman GM, Anderson PR, Bleicher RJ, Litwin S, Li T, Swaby RF, Ma CM, Li J, Sigurdson ER, Watkins-Bruner D, Morrow M, Goldstein LJ. Five-year local control in a Phase II study of hypofractionated intensity modulated radiation therapy with an incorporated boost for early stage breast cancer Int J Radiat Oncol Biol Phys. Forthcoming 2012.
  • Freedman GM, Li T, Polli LV, Anderson PR, Bleicher RJ, Sigurdson E, Swaby R, Dushkin H, Patchefsky A, Goldstein L. Lymphatic space invasion is not an independent predictor of outcomes in early stage breast cancer treated by breast-conserving surgery and radiation. Breast J. 2012; 18(5):415-9.
  • Fu J, Bassi DE, Zhang J, Li T, Nicolas E, Klein-Szanto AJ. Transgenic overexpression of the proprotein convertase furin enhances skin tumor growth. Neoplasia. 2012; 14(4):271-82.
  • Galloway TJ, Lango MN, Burtness B, Mehra R, Ruth K, Ridge JA. Unilateral neck therapy in the human papillomavirus ERA: Accepted regional spread patterns. Head Neck. Forthcoming 2012.
  • Hall MJ, Ruth K, Giri VN. Rates and predictors of colorectal cancer screening by race among motivated men participating in a prostate cancer risk assessment program, Cancer 2012; 118(2):478-84.
  • Heckman C, Zhu F, Manne SL, Kloss J, Collins B, Bass S, Lessin S. Process and outcomes of a skin protection intervention for young adults. J Health Psychol. Forthcoming 2012.
  • Hensley HH, Roder NA, O'Brien SW, Bickel LE, Xiao F, Litwin S, Connolly DC. Combined in vivo molecular and anatomic imaging for detection of ovarian carcinoma-associated protease activity and integrin expression in mice. Neoplasia 2012; 14(6):451-62.
  • Hughes L, Zhu F, Ross E, Gross L, Uzzo RG, Chen DY, Viterbo R, Rebbeck TR, Giri VN. Assessing the clinical role of genetic markers of early-onset prostate cancer among high-risk men enrolled in prostate cancer early detection. Cancer Epidemiol Biomarkers Prev. 2012; 21(1):53-60.
  • KellerLM, Buyyounouski MK, Sopka D, Ruth K, Klayton T, Pollack A, Watkins-Bruner D, Greenberg R, Price R, Horwitz EM. Stamp test delivers message on erectile dysfunction after high-dose intensity-modulated radiotherapy for prostate cancer. Urology. 2012; 80(2):337-42.
  • Klayton T, Li T, Yu JQ, Cheng J, Cohen SJ, Meropol N, Scott W, Welliver MX, Konski A. The role of qualitative and quantitative analysis of F18-FDG positron emission tomography in predicting pathologic response following chemoradiotherapy in patients with esophageal carcinoma. J Gastrointest Cancer. Forthcoming 2012.
  • Konski A, Li T, Christensen M, Cheng J, Yu JQ, Crawford K, Haluszka O, Tokar J, Scott W, Meropol NJ, Cohen SJ, Maurer A, Freedman GM. Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancer. Radiother Oncol. 2012 104(1):72-77.
  • Kutikov A, Rozenfeld B, Egleston BL, Sirohi M, Hwang RW, Uzzo RG. Academic ranking score: A publication-based reproducible metric of thought leadership in urology. Eur Urol, 2012; 61(3):435-39.
  • Kutikov A, Smaldone MC, Egleston BL, Uzzo RG. Should partial nephrectomy be offered to all patients whenever technically feasible? Eur Urol. 2012; 61(4):732-34.
  • Lee CK, Marschner I, Simes J, Voysey M, Egleston BL, Hudes G, de Souza PL. Increase in cholesterol predicts survival advantage in renal cell carcinoma patients treated with temsirolimus Clin Cancer Res. 2012; 18(11):3188-96.
  • Li H, Bitler BG, Vathipadiekal V, Maradeo ME, Slifker M, Creasy CL, Tummino PJ, Cairns P, Birrer MJ, Zhang R. ALDH1A1 is a novel EZH2 target gene in epithelial ovarian cancer identified by genome-wide approaches. Cancer Prev Res. 2012; 5(3):484-91.
  • Long CJ, Canter DJ, Kutikov A, Li T, Simhan J, Smaldone M, Teper E, Viterbo R, Boorjian SA, Chen DY, Greenberg RE, Uzzo RG. Partial nephrectomy for renal masses. Brit J Urol Int. 2012; 109(10):1450-56.
  • Lubbe W, Cohen R, Sharma N, Ruth K, Peters R, Li J, Buyyounouski M, Kutikov A, Chen D, Uzzo R, Horwitz E. Biochemical and clinical experience with real-time intraoperatively planned permanent prostate brachytherapy. Brachytherapy 2012; 11(3):209-13.
  • Miller SM, Hudson SV, Egleston BL, Manne S, Buzaglo JS, Devarajan K, Fleisher L, Millard J, Solarino N, Trinastic J, Meropol NJ. The relationships among knowledge self-efficacy preparedness decisional conflict and decisions to participate in a cancer clinical trial. Psychooncology. Forthcoming 2012.
  • Nitzkorski JR, Farma JM, Watson JC, Siripurapu V, Zhu F, Matteotti RS, Sigurdson ER. Outcome and natural history of patients with stage IV colorectal cancer receiving chemotherapy without primary tumor resection. Ann Surg Oncol, 2012; 9(2):379-83.
  • O'Donnell LA, Conway S, Rose RW, Nicolas E, Slifker M, Balachandran S, Rall GF. STAT1-independent control of a neurotropic measles virus challenge in primary neurons and infected mice. J Immunol. 2012; 188(4):1915-23.
  • Pahlajani N, Ruth KJ, Buyyounouski MK, Chen DY, Horwitz EM, Hanks GE, Price RA, Pollack A. Radiotherapy doses of 80 gy and higher are associated with lower mortality in men with Gleason score 8 to 10 prostate cancer. Int J Radiat Oncol Biol Phys. 2012; 82(5):1949-56.
  • Papavasiliou P, Arrangoiz R, Zhu F, Chun YS, Edwards K, Hoffman JP. The anatomic course of the first jejunal branch of the superior mesenteric vein in relation to the superior mesenteric artery. Int J Surg Oncol. 2012; 2012:538769.
  • Ratushny V, Pathak HB, Beeharry N, Tikhmyanova N, Xiao F, Li T, Litwin S, Connolly DC, Yen TJ, Weiner LM, Godwin AK, Golemis EA. Dual inhibition of SRC and Aurora kinases induces postmitotic attachment defects and cell death. Oncogene 2012; 31(10):1217-27.
  • Roberts JL, Buckley RH, Luo B, Pei J, Lapidus A, Peri S, Wei Q, Shin J, Parrott RE, Dunbrack RL Jr, Testa JR, Zhong XP, Wiest DL. CD45-deficient severe combined immunodeficiency caused by uniparental disomy. Proc Natl Acad Sci U S A. 2012; 109(26):10456-461.
  • Russo J, Santucci-Pereira J, de Cicco RL, Sheriff F, Russo PA, Peri S, Slifker M, Ross E, Mello ML, Vidal BC, Belitskaya-Lévy I, Arslan A, Zeleniuch-Jacquotte A, Bordas P, Lenner P, Ahman J, Afanasyeva Y, Hallmans G, Toniolo P, Russo IH. Pregnancy-induced chromatin remodeling in the breast of postmenopausal women. Int J Cancer. 2012; 131(5):1059-70.
  • Shanmugan S, Arrangoiz R, Nitzkorski JR, Yu JQ, Li T, Cooper H, Konski A, Farma JM, Sigurdson ER. Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using (18)FDG-PET/CT. Ann Surg Oncol. 2012; 19(7):2178-85.
  • Sill M, Rubinstein L, Litwin S, Yothers G. A method for utilizing bivariate efficacy outcome measures to screen regimens for activity in 2-stage phase II clinical trials. Clin Trials. 2012; 9(4):385-95.
  • Simhan J, Smaldone MC, Canter DJ, Zhu F, Starkey R, Stitzenberg KB, Uzzo RG, Kutikov A. Trends in regionalization of adrenalectomy to higher volume surgical centers. J Urol. 2012; 188(2):377-83.
  • Smaldone MC, Simhan J, Kutikov A, Canter DJ, Starkey R, Zhu F, Nielsen ME, Stitzenberg KB, Greenberg RE, Uzzo RG. Trends in regionalization of radical cystectomy in three large northeastern states from 1996 to 2009. Urol Oncol. Forthcoming 2012;
  • Smaldone MC, Kutikov A, Egleston B, Simhan J, Canter DJ, Teper E, Viterbo R, Chen DY, Greenberg RE, Uzzo RG. Assessing performance trends in laparoscopic nephrectomy and nephron-sparing surgery for localized renal tumors. Urology. 2012; 80(2):286-92.
  • Smaldone MC, Kutikov A, Egleston BL, Canter DJ, Veterbo R, Chen DY, Jewett MA, Greenberg RE, Uzzo RG. Small renal masses progressing to metastases under active surveillance: A systematic review and pooled analysis. Cancer 2012; 118(4):997-06.
  • Stitzenberg KB, Wong Y-N, Nielsen ME, Egleston BL, Uzzo RG. Trends in radical prostatectomy: centralization robotics and access to urologic cancer care. Cancer. 2012; 118(1):54-62.
  • Van Cleave JH, Egleston BL, Bourbonniere M, Cardone L, McCorkle R. Functional status in older women following gynecological cancer surgery: can choice of measure influence evidence for clinical practice? Geriatr Nurs. 2012; 33(2):118-26.
  • Weiss CO, Wolff JL, Egleston B, Seplaki CL, Fried LP. Incident preclinical mobility disability (PCMD) increases future risk of new difficulty walking and reduction in walking activity. Arch Gerontol Geriatr. 2012; 54(3):e329-33.
  • Wong YN, Litwin S, Vaughn D, Cohen S, Plimack ER, Lee J, Song W, Dabrow M, Brody M, Tuttle H, Hudes G. Phase II trial of cetuximab with or without paclitaxel in patients with advanced urothelial tract carcinoma. J Clin Oncol. Forthcoming 2012
  • Zaorsky NG, Buyyounouski MK, Li T, Horwitz EM. Aspirin and statin nonuse associated with early biochemical failure after prostate radiation therapy. Int J Radiat Oncol Biol Phys. 2012; 1;84(1):e13-7.
  • Zaorsky NG, Li T, Devarajan K, Horwitz EM, Buyyounouski MK. Assessment of the American Joint Committee on cancer staging (sixth and seventh editions) for clinically localized prostate cancer treated with external beam radiotherapy and comparison with the National Comprehensive Cancer Network risk-stratification method. Cancer. Forthcoming 2012.

2011

  • Anastassiadis T, Deacon S, Devarajan K, Ma H, Peterson J. Large-scale kinase inhibitor profiling reveals features of target selectivity Nat Biotechnol. 2011; 29(11):1039-49.
  • Ariazi EA, Cunliffe HE, Lewis-Wambi JS, Slifker MJ, Willis AL, Ramos P, Tapia C, Kim H, Smitha Y, Sharma C, Nicolas E, Balagurunathanb Y, Ross EA, Jordan VC. Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer via stress responses as identified by global gene expression Proc Natl Acad Sci. 2011; 108(47):18879-86.
  • Belitskaya-Lévy I, Zeleniuch-Jacquotte A, Russo J, Russo IH, Bordás P, Ahman J, Afanasyeva Y, Johansson R, Lenner P, Li X, de Cicco RL, Peri S, Ross E, Russo PA, Santucci-Pereira J, Sheriff FS, Slifker M, Hallmans G, Toniolo P, Arslan AA. Characterization of a genomic signature of pregnancy identified in the breast. Cancer Prev Res (Phila), 2011; 4(9):1457-64.
  • Bitler BG, Nicodemus JP, Li H, Cai Q, Wu H, Hua X, Li T, Birrer MJ, Godwin AK, Cairns P, Zhang R, Wnt5a suppresses epithelial ovarian cancer by promoting cellular senescence. Cancer Res. 2011; 71(19):6184-94.
  • Bradbury AR, Patrick-Miller L, Fetzer D, Egleston B, Cummings SA, Forman A, Bealin L, Peterson C, Corbman M, O’Connell J, Daly MB. Genetic counselor opinions of and experiences with telephone communication of BRCA1/2 test results. Clin Genet. 2011; 79(2):125-31.
  • Canter D, Kutikov A, Manley B, Egleston B, Simhan J, Smaldone M, Teper E, Viterbo R, Chen DY, Greenberg RE, Uzzo RG. Utility of the RENAL Nephrometry scoring system in objectifying treatment decision-making of the enhancing renal mass. Urology 2011; 78(5):1089-94.
  • Canter D, Long C, Kutikov A, Plimack E, Saad I, Oblaczynski M, Zhu F, Viterbo R, Chen DY, Uzzo RG, Greenberg RE, Boorjian SA. Clinicopathological outcomes after radical cystectomy for clinical T2 urothelial carcinoma: further evidence to support the use of neoadjuvant chemotherapy. BJU Int. 2011l 107:56-62.
  • Canter D, Viterbo R, Kutikov A, Wong YN, Plimack E, Zhu F, Oblaczynski M, Berberian R, Chen DY, Greenberg RE, Uzzo RG, Boorjian SA. Baseline renal function status limits patient eligibility to receive perioperative chemotherapy for invasive bladder cancer and is minimally affected by radical cystectomy Urology. 2011; 77(1):160-65.
  • Clapper ML, Hensley HH, Chang W-CL, Devarajan K, Nguyen MT, Cooper HS. Detection of colorectal adenomas using a bioactivatable probe specific for matrix metalloproteinase activity. Neoplasia. 2011; 13(8):685-91.
  • Cortellino S, Xu J, Sannai M, Moore R, Caretti E, Cigliano A, Le Coz M, Devarajan K, Wessels A, Soprano D, Abramowitz LK, Bartolomei MS, Rambow F, Bassi MR, Bruno T, Fanciulli M, Renner C, Klein-Szanto AJ, Matsumoto Y, Kobi D, Davidson I, Alberti C, Larue L, Bellacosa A. Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair. Cell. 2011; 146(1):67-79.
  • Devarajan K, Ebrahimi N. A semi-parametric generalization of the Cox proportional hazards regression model: Inference and Applications. Comput Stat Data Anal. 2011; 55:667-76.
  • Egleston BL. Response to Pearl's comments on principal stratification Int J Biostat. 2011; 7(1) pii: Article 24.
  • Egleston BL, Miller SM, Meropol NJ. The impact of misclassification due to survey response fatigue on estimation and identifiability of treatment effects, Stat Med. 2011; 30(30):3560-72 2011.
  • Frank AK, Leu JI, Zhou Y, Devarajan K, Nedelko T, Klein-Szanto A, Hollstein M, Murphy ME. The codon 72 polymorphism of p53 regulates interaction with NF-kB and transactivation of genes involved in immunity and inflammation. Mol Cell Biol. 2011; 31(6):1201-13.
  • Giri VN, Ruth K, Hughes L, Uzzo RG, Chen DY, Boorjian SA, Viterbo R, Rebbeck TR. Racial differences in prediction of time to prostate cancer diagnosis in a prospective screening cohort of high-risk men: effect of TMPRSS2 Met160Val. Br J Urol. 2011; 107:466-70.
  • Gupta V, Bassi DE, Simons JD, Devarajan K, Al-Saleem TI, Uzzo RG, Cukierman E. Elevated expression of stromal paladin predicts poor clinical outcome in renal cell carcinoma. PLoS ONE. 2011; 6(6):e21494.
  • Haiman CA, Chen GK, Vachon CM, Canzian F, Dunning A, Millikan RC, Wang X, Ademuyiwa F, Ahmed S, Ambrosone CB, Baglietto L, Balleine R, Bandera EV, Beckmann MW, Berg CD, Bernstein L, Blomqvist C, Blot WJ, Brauch H, Buring JE, Carey LA, Carpenter JE, Chang-Claude J, Chanock SJ, Chasman DI, Clarke CL, Cox A, Cross SS, Deming SL, Diasio RB, Dimopoulos AM, Driver WR, Dünnebier T, Durcan L, Eccles D, Edlund CK, Ekici AB, Fasching PA, Feigelson HS, Flesch-Janys D, Fostira F, Försti A, Fountzilas G, Gerty SM, The Gene Environment Interaction and Breast Cancer in Germany (GENICA) Consortium, Giles GG, Godwin AK, Goodfellow P, Graham N, Greco D, Hamann U, Hankinson SE, Hartmann A, Hein R, Heinz J, Holbrook A, Hoover RN, Hu JJ, Hunter DJ, Ingles SA, Irwanto A, Ivanovich J, John EM, Johnson N, Jukkola-Vuorinen A, Kaaks R, Ko YD, Kolonel LN, Konstantopoulou I, Kosma VM, Kulkarni S, Lambrechts D, Lee AM, Marchand LL, Lesnick T, Liu J, Lindstrom S, Mannermaa A, Margolin S, Martin NG, Miron P, Montgomery GW, Nevanlinna H, Nickels S, Nyante S, Olswold C, Palmer J, Pathak H, Pectasides D, Perou CM, Peto J, Pharoah PD, Pooler LC, Press MF, Pylkäs K, Rebbeck TR, Rodriguez-Gil JL, Rosenberg L, Ross E, Rüdiger T, Silva ID, Sawyer E, Schmidt MK, Schulz-Wendtland R, Schumacher F, Severi G, Sheng X, Signorello LB, Sinn HP, Stevens KN, Southey MC, Tapper WJ, Tomlinson I, Hogervorst FB, Wauters E, Weaver J, Wildiers H, Winqvist R, Berg DV, Wan P, Xia LY, Yannoukakos D, Zheng W, Ziegler RG, Siddiq A, Slager SL, Stram DO, Easton D, Kraft P, Henderson BE, Couch FJ. A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nature Genetics. 2011; 43(12):1210-14.
  • Klayton TL, Ruth K, Buyyounouski MK, Uzzo RG, Wong YN, Chen DY, Sobczak M, Peter R, Horwitz EM. PSA doubling time predicts for the development of distant metastases for patients who fail 3DCRT or IMRT using the phoenix definition. Pract Radiat Oncol. 2011; 1(4):235-42.
  • Klayton TL, Ruth K, Horwitz EM, Uzzo RG, Kutikov A, Chen DY, Sobczak M, Buyyounouski MK. Young age under 60 years is not a contraindication to treatment with definitive dose escalated radiotherapy for prostate cancer. Radiother Oncol. 2011; 101(3):508-12.
  • Kutikov A, Piotrowski ZJ, Piotrowski ZJ, Canter DJ, Li T, Chen DYT, Viterbo R, Greenberg RE, Boorjian SA, Uzzo RG. Routine adrenalectomy is unnecessary during surgery for large and/or upper pole renal tumors when the adrenal gland is radiographically normal. J Urol. 2011; 185(4):1198-03.
  • Kutikov A, Smaldone MC, Egleston BL, Manley BJ, Canter DJ, Simhan J, Boorjian SA, Viterbo R, Chen DY, Greenberg RE, Uzzo RG. Anatomic features of enhancing renal masses predict malignant and high-grade pathology: A preoperative nomogram using the RENAL nephrometry score. Eur Urol. 2011; 60(2):241-48.
  • Lee HO, Silva AS, Concilio S, Li YS, Slifker M, Gatenby RA, Cheng JD. Evolution of tumor invasiveness: the adaptive tumor microenvironment landscape model. Cancer Res 2011; 71(20):6327-37.
  • Long CJ, Kutikov A, Canter DJ, Egleston BL, Chen DY, Veterbo R, Boorjian SA, Uzzo RG. Percutaneous vs surgical cryoablation of the small renal mass: Is efficacy compromised? Br J Urol Int. 2011; 107(9):1376-80.
  • Makhlin I, Zhang J, Long CJ, Devarajan K, Zhou Y, Klein-Szanto AJ, Huang M, Chernoff J, Boorjian SA. The mTOR pathway affects proliferation and chemosensitivity of urothelial carcinoma cells and is upregulated in a subset of human bladder cancers. Brit J Urol. 2011; 108:(2B):E84-E90.
  • Murphy C, Anderson PR, Li T, Bleicher RJ, Sigurdson ER, Goldstein LJ, Swaby R, Denlinger C, Dushkin H, Nicolaou N, Freedman GM. Impact of the radiation boost on outcomes after breast-conserving surgery and radiation. Int J Radiat Oncol Biol Phys. 2011; 81(1):69-76.
  • Mustafa A, Gupta S, Hudes GR, Egleston BL, Uzzo RG, Kruger WD. Serum amino acid levels as a biomarker for renal cell carcinoma. J Urol. 2011; 186(4):1206-12.
  • Patel RR, Li T, Ross EA, Sesa L, Sigurdson ER, Bleicher RJ. The effect of simultaneous peripheral excision in breast conservation upon margin status. Ann Surg Oncol. 2011; 17(11):2933-39.
  • Sasaroli D, Gimotty P, Pathak H, Hammond R, Kougioumtzidou E, Katsaros D, Buckanovich R, Devarajan K, Sandaltzopoulos R, Godwin A, Scholler N. Novel surface targets and serum biomarkers from the ovarian cancer vasculature. Cancer Biol Therapy. 2011; 12(3):169-80.
  • Sharma NK, Li T, Chen DY, Pollack A, Horwitz EM, Buyyounouski MK. Intensity-modulated radiotherapy reduces gastrointestinal toxicity in patients treated with androgen deprivation therapy for prostate cancer. Intl J Rad Oncol Biol Phy. 2011; 80(2):437-44.
  • Sharma NK, Silverman JS, Li T, Cheng J, Yu JQ, Haluszka O, Scott W, Meropol NJ, Cohen SJ, Freedman GM, Konski AA. Decreased posttreatment SUV on PET scan is associated with improved local control in medically inoperable esophageal cancer. Gastrointest Cancer Res. 2011; 4(3):84-89.
  • Shatalova EG, Klein-Szanto AJ, Devarajan K, Cukierman E, Clapper ML. Estrogen and cytochrome P450 1B1 contribute to both early- and late-stage head and neck carcinogenesis. Cancer Prev Res. 2011; 4:107-15.
  • Shaw CM, Stanczyk FZ, Egleston BL, Kahle LL, Spittle CS, Godwin AK, Brinton LA, Dorgan JF. Serum antimüllerian hormone in healthy premenopausal women. Fertil Steril. 2011; 95(8):2718-21.
  • Simhan J, Smaldone MC, Tsai KJ, Canter DJ, Li T, Kutikov A, Viterbo R, Chen DY, Greenberg RE, Uzzo RG. Objective measures of renal mass anatomic complexity predict rates of major complications following partial nephrectomy, Eur Urol, 2011; 60(4):724-30.
  • Stevens KN, Vachon CM, Lee AM, Slager S, Lesnick T, Olswold C, Fasching PA, Miron P, Eccles D, Carpenter JE, Godwin AK, Ambrosone C, Winqvist R, Brauch H, Schmidt MK, Cox A, Cross SS, Sawyer E, Hartmann A, Beckmann MW, Schulz-Wendtland R, Ekici AB, Tapper WJ, Gerty SM, Durcan L, Graham N, Hein R, Nickels S, Flesch-Janys D, Heinz J, Sinn HP, Konstantopoulou I, Fostira F, Pectasides D, Dimopoulos AM, Fountzilas G, Clarke CL, Balleine R, Olson JE, Fredericksen Z, Diasio RB, Pathak HB, Ross E, Weaver J, Rüdiger T, Försti A, Dünnebier T, Ademuyiwa F, Kulkarni S, Pylkäs K, Jukkola-Vuorinen A, Ko YD, Van Limbergen E, Janssen H, Peto J, Fletcher O, Giles GG, Baglietto L, Verhoef S, Tomlinson I, Kosma VM, Beesley J, Greco D, Blomqvist C, Irwanto A, Liu J, Blows FM, Dawson SJ, Margolin S, Mannermaa A, Martin NG, Montgomery GW, Lambrechts D, Dos Santos Silva I, Severi G, Hamann U, Pharoah P, Easton DF, Chang-Claude J, Yannoukakos D, Nevanlinna H, Wang X, Couch FJ. Common breast cancer susceptibility loci are associated with triple negative breast cancer. Cancer Res. 2011; 71(19):6240-49.
  • Thapa RJ, Basagoudanavar S, Nogusa S, Irrinki K, Mallilankaraman K, Slifker MJ, Beg AA, Madesh M, Balachandran S. NF-{kappa}B protects cells from interferon -{gamma}-induced RIP1-dependent necroptosis. Mol Cell Biol. 2011; 31(14):2934-46.
  • Turaka A, Li T, Nicolaou N, Lango MN, Burtness B, Horwitz EM, Ridge JA, Feigenberg SJ. Use of a conventional low neck field (LNF) and intensity-modulated radiotherapy (IMRT): no clinical detriment of IMRT to an anterior LNF during the treatment of head-and neck-cancer. Int J Rad Oncol Biol Phys. 2011; 79(1): 65-70.
  • Van Cleave JH, Egleston BL, Bourbonniere M, McCorkle R Combining extant datasets with differing outcomes measures across studies of older adults after cancer surgery. Res Gerontol Nurs. 2011; 4(1):36-46.
  • Van Cleave JH, Egleston BL, McCorkle R. Factors affecting recovery of functional status in older adults after cancer surgery . J Am Geriatr Soc. 2011; 59(1):34-43.

2010

  • Abramowitz MC, Li T, Morrow M, Anderson PR, Bleicher RJ, Goldstein LJ ,Swaby R, Nicolaou N, Freedman G. History of smoking is associated with younger age at diagnosis of breast cancer Breast J. 2010;16:344-9.
  • Ariazi EA, Brailoiu E, Yerrum S, Shupp HA, Slifker MJ, Cunliffe HE, Black MA, Donato AL, Arterburn JB, Oprea TI, Prossnitz ER, Dun NJ, Jordan VC.  The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells  Cancer Res. 2010;70:1184-94.
  • Astsaturov I, Ratushny V, Sukhanova A, Einarson MB, Bagnyukova T, Zhou Y, Devarajan K, Silverman JS, Tikhmyanova N, Skobeleva N, Pecherskaya A, Nasto RE, Sharma C, Jablonski SA, Serebriiskii IG, Weiner LM, Golemis EA. Synthetic lethal screen of an EGFR-centered network to improve targeted therapies. Sci Signal. 2010; 3(140):ra67.
  • Devarajan K, Zhou Y, Chachra N, Ebrahimi N. A supervised approach for predicting patient survival with gene expression data. Proc IEEE Int Symp Bioinformatics Bioeng. 2010;2010(5521718):26-31.
  • Ivy BS, Devarajan K, Sundaram CP Bilateral oncocytoma and the value of needle biopsy. Can J Urol. 2010; 17:5131-34.
  • Bellacosa A, Godwin AK, Peri S, Devarajan K, Caretti E, Vanderveer L, Bove B, Slater C, Zhou Y, Daly M, Howard S, Campbell KS, Nicolas E, Yeung AT, Clapper ML, Crowell JA, Lynch HT, Ross E, Kopelovich L, Knudson AG .Altered gene expression in morphologically normal epithelial cells from heterozygous carriers of BRCA1 or BRCA2 mutations. Cancer Prev Res. 2010;3:48-61.
  • Boorjian SA, Zhu F, Herr HW. The effect of gender on response to bacillus Calmette-Guérin therapy for patients with non-muscle-invasive urothelial carcinoma of the bladder. BJU. 2010;106:357-61.
  • Cohen RJ, Paskalev K, Litwin S, Price Jr RA, Feigenberg SJ, Konski AA, Esophageal motion during radiotherapy: quantification and margin implications. Dis Esophagus. 2010;23(6)473-9.
  • Dorgan JF, Spittle CS, Egleston BL, Shaw CM, Kahle LL, Brinton LA. Assay reproducibility and within-person variation of mullerian inhibiting substance .Fertil Steril. 2010;94:301-03.
  • Egleston BL, Chandler DW, Dorgan JF. Validity of estimating non-SHBG bound testosterone and estradiol from total hormone measurements in boys and girls. Ann Clin Biochem. 2010; 47(Pt 3):233-41.
  • Egleston BL, Cropsey KL, Lazev AB, Heckman CJ. Tutorial on principal stratification-based sensitivity analysis: Application to smoking cessation studies. Clinical Trials 2010; 7(3):286-98.
  • Egleston BL, Dunbrack RL Jr, Hall MJ. Clinical trials that explicitly exclude gay and lesbian patients. N EngJ Med. 2010; 362(11):1054-55.
  • Freedman GM, Li T, Anderson PR, Nicolaou N, Konski A. Health states of women after conservative surgery and radiation for breast cancer. Breast Cancer Res Treat. 2010; 121(2):519-26.
  • Hall MJ, Egleston B, Miller SM, Buzaglo JS, Millard J, Ridgway C, Damjanov N, Sprandio JD, Meropol NJ. Barriers to participation in cancer prevention clinical trials. Acat Oncol 2010; 49:757-66.
  • Hegde SR, Iffrig K, Li T, Downey S, Heller SJ, Tokar JL, Haluszka O. Double-balloon enteroscopy in the elderly: safety findings and diagnostic and therapeutic success. Gastrointest Endosc. 2010;71(6):983-89.
  • Kaplan DJ, Boorjian SA, Ruth K, Egleston BL, Chen DY, Viterbo R, Uzzo RG, Buyyounouski MK, Raysor S, Giri VN. Evaluation of the prostate cancer prevention trial risk calculator in high-risk screening population. BJU Int.2010;105:334-37.
  • Kutikov A, Egleston BL, Wong YN, Uzzo RG. Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram. J Clin Oncol. 2010; 28(2):311-17.
  • Lango MN, Egleston B, Ende K, Feigenberg S, D'Ambrisio DJ, Cohen RB, Ahmad S, Nicolaou N, Ridge JA. Impact of neck dissection on long-term feeding tube dependence in patients with head and neck cancer treated with primary radiation or chemoradiation. Head Neck. 2010; 32(3):341-47.
  • Manne SL, Meropol NJ, Weinberg DS, Vig H, Catts ZA-K, Manning C, Ross E, Shannon K, Chung D. Facilitating informed decision regarding microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer. J Clin Oncol. 2010; 28(8):1366-72.
  • Mason WS, Liu C, Aldrich CE, Litwin S, Yeh MM. Clonal expansion of normal-appearing human hepatocytes during chronic hepatitis B virus infection. J Virol. 2010; 84:8308-15.
  • Meireles SI, Esteves GH, Hirata R, Peri S, Devarajan K, Slifker M, Mosier SL, Vadhanam MV, Hurst HE, Neves EJ, Reis LF, Gairola CG, Gupta RC, Clapper ML. Early changes in gene expression induced by tobacco smoke: evidence for the importance of estrogen within lung tissue. Cancer Prev Res. 2010;3(6):707-17.
  • Patel, R.R., Li, T., Ross, E.A., Sesa, L., Sigurdson, E.R., Bleicher, R.J. The effect of simultaneous peripheral excision in breast conservation upon margin status. Ann Surg Oncol. 2010 17(11):2933-39.
  • Roussi P, Sherman KA, Miller S, Buzaglo J, Daly M, Taylor A. Ross E, Godwin A. Enhanced counselling for women undergoing BRCA1/2 testing: impact on knowledge and psychological distress - results from a randomised clinical trial. Psychol Health. 2010; 25:401-15.
  • Scott WJ, Mateotti RS, Egleston BL, Oseni S, Flaherty JF. A comparison of perioperative outcomes of Video-Assisted Thoracic Surgical (VATS) Lobectomy with open thoracotomy and lobectomy: Results of an analysis using propensity score based weighting. Ann Surg Innov Res. 2010;4(1):1-6.
  • Sharma NK, Cohen RJ, Eade TN, Buyyounouski MK, Uzzo RG, Li T, Crawford K, Chen DY, McNeeley S, Horwitz EM. An intraoperative real-time sleeved seed technique for permanent prostate brachytherapy. Brachytherapy. 2010; 9(2):126-30.
  • Silvers RM, Smith JA, Schowalter M, Litwin S, Liang Z, Geary K, Daniel R. Modification of integration site preferences of an HIV-1-based vector by expression of a novel synthetic protein. Hum Gene Ther. 2010;21(3): 337-49.
  • vonHolzen U, Chen T, Boquoi A, Richter JE, Falk GW, Klein-Szanto AJ, Cooper H, Litwin S, Weinberg DS, Enders GH. Evidence for DNA damage checkpoint activation in barrett esophagus. Transl Oncol. 2010; 3:33-42.
  • Wang C, Miller SM, Egleston BL, Hay JL, Weinberg DS. Beliefs about the causes of breast and colorectal cancer among women in the general population. Cancer Causes Control. 2010; 99:107-10.
  • Wong YN, Hamilton O, Egleston BL, Salador K, Murphy C, Meropol NJ. Understanding how out of pocket expenses treatment value and patient characteristics influence treatment choices. Oncologist. 2010; 15(6):566-76.
  • Xu XZ, Garcia MV, Li T, Khor LY, Gajapathy RS, Spittle C, Weed S, Lessin SR, Wu H. Cytoskeleton alterations in melanoma: aberrant expression of cortactin an actin-binding adapter protein correlates with melanocytic tumor progression. Mod Pathol. 2010; 23(2):187-96.

2009

  • Abramowitz MC, Li T, Morrow M, Sigurdson ER, Anderson P, Nicolaou N, Freedman G. Dermal lymphatic invasion and inflammatory breast cancer are independent predictors of outcome after postmastectomy radiation Am J Clin Oncol. 2009;32:30-3.
  • Amin RH, Cado D, Nolla H, Huang D, Shinton SA, Zhou Y, Hardy RR, Schlissel MS. Biallelic ubiquitous transcription from the distal germline lg kappa locus promoter during B cell development Proc Natl Acad Sci USA .2009;106:522-27.
  • Anderson PR, Freedman G, Nicolaou N, Sharma N, Li T, Topham N, Morrow M. Postmastectomy chest wall radiation to a temporary tissue expander or permanent breast implant—Is there a difference in complication rates? Int J Radia Onco Bio Phys. 2009;74:81-5.
  • Bleicher RJ, Ciocca RM, Egleston BL, Sesa L, Evers K, Sigurdson ER, Morrow M. Association of routine pretreatment magnetic resonance imaging with time to surgery mastectomy rate and margin status. J Am Coll Surg. 2009;209:180-87; quiz 294-95.
  • Burtness B, Gibson M, Egleston B, Mehra R, Thomas L, Sipples R, Quintanilla M, Lacy J, Watkins S, Murren JR. Forastiere AA Phase II trial of docetaxel-irinotecan combination in advanced esophageal cancer. Ann Oncol. 2009; 20:1242-48.
  • Coups EJ, Park BJ, Feinstein MB, Steingart RM, Egleston BL, Wilson DJ, Ostroff JS. Correlates of physical activity among lung cancer survivors Psychooncology. 2009;18:395-404.
  • Coups EJ, Park BJ, Feinstein MB, Steingart RM, Egleston BL, Wilson DJ, Ostroff JS. Physical activity among lung cancer survivors: changes across the cancer trajectory and associations with quality of life Cancer Epidemiol Biomarkers Prev. 2009;18:664-72.
  • Denlinger CS, Blanchard R, Xu L, Bernaards C, Litwin S, Spittle C, Berg DJ, McLaughlin S, Redlinger M, Dorr A, Hambleton J, Holden S, Kearns A, Kenkare-Mitra S, Lum B, Meropol NJ, O'Dwyer PJ. Pharmacokinetic analysis of irinotecan plus bevacizumab in patients with advanced solid tumors Cancer Chemother Pharmacol. 2009;65:97-105.
  • Devarajan K, Ebrahimi N. Testing for covariate effect in the Cox proportional hazards regression model. Commun Stat Theory Methods. 2009;38:2333-37.
  • Dorgan JF, Stanczyk FZ, Egleston BL, Kahle LL, Shaw CM, Spittle CS, Godwin AK, Brinton LA. Prospective case-control study of serum Mϋllerian inhibiting substance and breast cancer risk. J Natl Cancer Inst. 2009; 101:1501-09.
  • Egleston BL, Meireles SI, Flieder DB, Clapper ML. Population-based trends in lung cancer incidence in women. Semin Oncol. 2009; 36:506-15.
  • Egleston BL, Scharfstein DO, Mackenzie E. On estimation of the survivor average causal effect in observational studies when important confounders are missing due to death. Biometrics. 2009; 65:497-504.
  • Egleston BL, Wong Y-N. Sensitivity analysis to investigate the impact of a missing covariate on survival analyses using cancer registry data. Stat Med. 2009; 28:1498-1511.
  • Fang CY, Cherry C, Devarajan K, Li T, Malick J, Daly MB. A prospective study of quality of life among women undergoing risk-reducing salpingo-ophorectomy versus gynecologic screening for ovarian cancer. Gynecol Oncol. 2009;112:594-600.
  • Fang CY, Egleston BL, Brown KM, Lavigne JV, Stevens VJ, Barton BA, Chandler DW, Dorgan JF. Family cohesion moderates the relation between free testosterone and delinquent behaviors in adolescent boys and girls. J Adolesc Health. 2009; 44:590-97.
  • Freedman GM, Anderson PR, Li T, Nicolaou N. Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation .Cancer. 2009;115:946-51.
  • Freedman GM, Li T, Nicolaou N, Chen Y, Ma CC, Anderson PR. Breast intensity modulated radiation therapy reduces time spent with acute dermatitis for women of all breast sizes during radiation. Int J Radiat Oncol Biol Phys. 2009;74:689-94.
  • Giri V, Egleston BL, Ruth K, Uzzo RG, Chen DYT, Buyyounouski M, Raysor S, Hooker S. Race genetic West African ancestry and prostate cancer prediction by PSA in prospectively screened high-risk men. Cancer Prev Res 2009;2:244-50.
  • Giri VN, Coups EJ, Ruth K, Goplerud J, Raysor S, Kim TY, Bagden L, Mastalski K, Zakrzewski D, Leimkuhler S, Watkins-Bruner D. Prostate cancer early detection program recruitment methods and show rates in men at high risk. J Urol. 2009; 182:2212-17.
  • Gupta S, Kϋhnisch J, Mustafa A, Lhotak S, Schlachterman A, Slifker MJ, Klein-Szanto A. High KA Austin RC Kruger WD  Mouse models of cystathionine {beta}-synthase deficiency reveal significant threshold effects of hyperhomocysteinemia.  FASEB J. 2009; 23(3):883-93.
  • Haley M, Konski A, Li T, Cheng JD, Maurer A, Haluszka O, Scott W, Meropol NJ, Cohen SJ, Freedman G. Influence of Diabetes on the Interpretation of PET Scans in patients with esophageal cancer. Gastrointest Cancer Res 2009; 3:149-52.
  • Hensley HH, Merkel CE, Chang W-C, Devarajan K, Cooper HS, Clapper ML. Endoscopic imaging and size estimation of colorectal adenomas in the multiple intestinal neoplasia mouse. Gastrointest Endosc. 2009; 69:742-49.
  • Izumchenko E, Singh MK, Plotnikova OV, Tikhmyanova N, Little JL, Serebriiskii IG, Seo S, Kurokawa M, Egleston BL, Klein-Szanto A, Pugacheva EN, Hardy RR, Wolfson M, Connolly DC, Golemis EA. NEDD9 promotes oncogenic signaling in mannary tumor development. Cancer Res.2009; 69:7198-06.
  • Kashyap MK, Marimuthu A, Kishore CJ, Peri S, Keerthikumar S, Prasad TS, Mahmood R, Rao S, Ranganathan P, Vijayakumar M, Kumar KV, Montgomery E, Kumar RV, Pandey A. Genomewide mRNA profiling of esophageal squamous cell carcinoma for identification of cancer biomarkers. Cancer Biol Ther. 2009; 8:36-46.
  • Ke E, Patel BB, Liu T, Li XM, Haluszka O, Hoffman JP, Ehya H, Young NA, Watson JC, Weinberg DS, Nguyen MT, Cohen SJ, Meropol NJ, Litwin S, Tokar JL, Yeung AT. Proteomic analyses of pancreatic cyst fluids. Pancreas.2009; 38:e33-42.
  • Konski A, Li T, Sigurdson E, Cohen SJ, Small W Jr, Spies S, Yu JQ, Wahl A, Stryker S, Meropol NJ. Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation. Int J Radiat Oncol Biol Phys. 2009; 74:55-59.
  • Kurland BF, Johnson LL, Egleston BL, Diehr PH. Longitudinal data with follow-up truncated by death: match the analysis method to research aims. Stat Sci. 2009; 24(2):211.
  • Mason WS, Low HC, Xu C, Aldrich CE, Scougall CA, Grosse A, Clouston A, Chavez D, Litwin S, Peri S, Jilbert AR, Lanford RE. Detection of clonally expanded hepatocytes in chimpanzees with chronic hepatitis B virus infection. J Virol. 2009; 83:8396-08.
  • Mason WS, Xu C, Low HC, Saputelli J, Aldrich CE, Scougall C, Grosse A, Colonno R, Litwin S, Jilbert AR. The amount of hepatocyte turnover that occurred during resolution of transient hepadnavirus infections was lower when virus replication was inhibited with entecavir. J Virol. 2009;83:1778-89.
  • Min H, Manion FJ, Goralczyke E, Wong YN, Ross E, Beck JR. Integration of prostate cancer clinical data using an ontology. J Biomed Inform. 2009; 42:1035-45.
  • Rhodes J, Amsterdam A, Sanda T, Moreau LA, McKenna K, Heinrichs S, Ganem NJ, Ho KW, Neuberg DS, Johnson A, Ahn Y, Kotok JL, Hromas R, Wray J, Lee C, Murphy C, Radke I, Downing JR, Fleming MD, Macconaill LE, Amatruda JF, Gutierrez A, Galinsky I, Stone RM, Ross EA, Pellman DS, Kanki JP. Look AT Emi1 maintains genomic integrity during Zebrafish embryogenesis and cooperates with p53 in tumor suppression. Mol Cell Biol. 2009; 29:5911-22.
  • Rothman J, Wong YN, Egleston B, Iffrig K, Lebovitch S, Uzzo RG., Histopathologic characteristics of localized renal cell carcinoma correlate with tumor size: A SEER Analysis. J Urol. 2009; 181:29-33; discussion 33-34.
  • Schilder RJ, Pathak HB, Lokshin A, Holloway RW, Alvarez RD, Aghajanian C, Min H, Devarajan K, Ross E, Drescher CW, Godwin AK. Phase II Trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash. Gynecol Oncol. 2009; 113:21-27.
  • Scholl BJ, Wong YN, Egleston BL, Kunkle DA, Saad IR, Uzzo RG. Age tumor size and relative survival of localized renal cell carcinoma: A survelliance epidemiology and end results analysis. J Urol. 2009; 181:506-11.
  • Sharkey RM, Karacay H, Johnson CR, Litwin S, Rossi EA, McBride WJ, Chang CH, Goldenberg DM. Pretargeted versus directly targeted radioimmunotherapy combined with anti-CD20 antibody consolidation therapy of Non-Hodgkin lymphoma. J Nucl Med. 2009; 50:444-53.
  • Stitzenberg KB, Sigurdson ER, Egleston BL, Starkey RB, Meropol NJ. Centralization of cancer surgery: Implications for patient access to optimal care. J Clin Oncol. 2009; 27:4671-78.
  • Turaka A, Freedman G, Li T, Bleicher R, Swaby R, Nicolaou N, Goldstein L, Sigurdson E, Anderson P. Young age is not associated with increased local recurrence for DCIS treated by breast-conserving surgery and radiation. J Surg Oncol. 2009; 100:25-31.
  • Vig HS, Armstrong J, Egleston BL, Mazar C, Toscano M, Bradbury AR, Daly MB, Meropol NJ. Cancer genetic risk assessment and referral patterns in primary care. Genet Test Mol Biomarkers. 2009; 13:735-41.
  • Weinberg D, Buzaglo J, Rodoletz M, Egleston B. Colorectal cancer knowledge is not associated with screening compliance or intention. J Cancer Educ Res. 2009;24:225-32.
  • Wong YN, Freedland S, Egleston BL, Hudes G. The role of androgen deprivation therapy in node positive prostate cancer. J Clin Oncol. 2009; 27:100-05.

2008

  • Abramowitz MC, Li T, Buyyounouski MK, Ross E, Uzzo RG, Pollack A, Horowitz EM. The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer. Cancer. 2008;112(1):55-60.
  • Barsevick AM, Montgomery SV, Ruth K, Ross EA, Egleston BL, Bingler R, Malick J, Miller SM, Cescon TP, Daly MB. Intention to communicate BRCA1/BRCA2 genetic test results to the family J Fam Psychol. 2008; 22:303-12.
  • Bleicher R, O'Sullivan M, Ciocca R, Ciocca V, Perkins LA, Ross E, Li T, Patchefsky A, Sigurdson ER, Joseph N, Sesa L, Morrow M. A prospective feasibility trial to determine the significance of the sentinel node gradient in breast cancer: A predictor of nodal metastasis location. Cancer. 2008; 113:3100-07.
  • Borghaei H, Langer CJ, Millenson M, Ruth KJ, Litwin S, Tuttle H, Seldomridge JS, Rovito M, Mintzer D, Cohen R, Treat J. Phase II study of paclitaxel carboplatin and cetuximab as first line treatment for patients with advanced non-small cell lung cancer (NSCLC): results of OPN-017. J Thora Oncol. 2008;3:1286-92.
  • Brown KM, Siripurapu V, Davidson M, Cohen SJ, Konski A, Watson JC, Li T, Ciocca V, Cooper H, Hoffman JP. Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma. Am J Surg. 2008;195:318-21.
  • Caretti E, Devarajan K, Coudry R, Ross E, Clapper ML, Cooper HS, Bellacosa A. Comparison of RNA amplification methods and chip platforms for microarray analysis of samples processed by laser capture microdissection. J Cell Biochem. 2008;103:556-63.
  • Ciocca RM, Li T, Freedman GM, Morrow M. Presence of lobular carcinoma in situ does not increase local recurrence in patients treated with breast-conserving therapy. Ann Surg Oncol. 2008;15:2263-71.
  • Clapper ML, Gary MA, Coudry RA, Litwin S, Chang WL, Devarajan K, Lubet RA, Cooper HS. 5-aminosalicylic acid inhibits colitis-associated colorectal dysplasias in the mouse model of azoxymethane/ dextran sulfate sodium-induced colitis. Inflamm Bowel Dis. 2008;14:1341-47.
  • D'Ambrosio DJ, Li T, Horwitz EM, Chen DY, Pollack A, Buyyounouski MK. Does treatment duration affect outcome after radiotherapy for prostate cancer? Int J Radiat Oncol Biol Phys. 2008;72:1402-07.
  • D'Ambrosio DJ, Ruth K, Horwitz EM, Chen DY, Pollack A, Buyyounouski MK. Does transurethral resection of prostate (TURP) affect outcome in patients who subsequently develop prostate cancer? Urology. 2008;71:938-41.
  • D'Ambrosio DJ, Ruth K, Horwitz EM, Uzzo RG, Pollack A, Buyyounouski MK. How can men destined for biochemical failure after androgen deprivation and radiotherapy be identified earlier? Int J Rad Oncol Biol Phys. 2008; 70:1489-91.
  • Devarajan K. Non-negative matrix factorization – An analytical and interpretive tool in computational biology. PLoS Comput Bio. 2008; 4:e1000029.
  • Devarajan K, Ebrahimi N. Class discovery via nonnegative matrix factorization. Am J ManageMath Sci. 2008;28:457-67.
  • Eade TN, Horwitz EM, Ruth K, Buyyounouski MK, D'Ambrosio DJ, Feigenberg SJ, Chen DY, Pollack A. A comparison of acute and chronic toxicity for men and low-risk prostate cancer treated with intensity-modulated radiation therapy or (125)I permanent implant. Int J Radiat Oncol Biol Phys.2008; 71:338-45.
  • Fleisher L, Buzaglo J, Collins M, Millard J, Miller SM, Egleston BL, Solarino N, Trinastic J, Cegala DJ, Benson AB 3rd, Schulman KA, Weinfurt KP, Sulmasy D, Diefenback MA, Meropol NJ. Using health communication best practices to develop a web-based provider-patient communication aid: The CONNECT trade mark study Patient Educ Couns. 2008; 71:376-87.
  • Fu J, Fong K, Bellacosa A, Ross E, Apostolou S, Bassi DE, Jin F, Zhang J, Cairns P. VILIP-1/ downregulation in non-small cell lung carcinomas: Mechanisms and prediction of survival. PLos One. 2008; 3:e1698.
  • Haile R, Daly M, Godwin A, Ross E, Beck J, Terry MB, Buys SS, Whittemore AS, John EM, Felberg A, McGuire V, West DW, Miron A, Thomas DC. Smoking and risk of breast cancer in carriers of mutations in BRCA1 or BRCA2 aged less than 50 years. Breast Cancer Res Treat. 2008;109:67-75.
  • Hayes SB, Freedman GM, Li T, Anderson PR, Ross E. Does axillary boost increase lymphedema compared with supraclavicular radiation alone after breast conservation? Int J Radiat Oncol Biol Phys. 2008; 72:1449-55.
  • Heckman CJ, Egleston BL, Wilson DB, Ingersoll KS. A preliminary investigation of the predictors of tanning dependence. Am J Health Behav 2008; 32:451-64.
  • Huang CH, Millenson MM, Sherman EJ, Borghaei H, Mintzer DM, Cohen RB, Staddon AP, Seldomridge J, Treat OJ, Tuttle H, Ruth KJ, Langer CJ. Promising survival in patients with recurrent non-small cell lung cancer treated with docetaxel and gemcitabine in combination as second-line therapy. J Thorac Oncol. 2008; 3:1032-38.
  • Kunkle DA, Egleston BL, Uzzo RG. Excise ablate or observe: the small renal mass dilemma - a meta-analysis and review. J Urol. 2008; 179:1227-33.
  • Lessin SR, Ross EA, Wu H. Treatment of parapsoriasis with Bexarotene 1%. Gel Internatl J Dermatol. 2008; 47:1325-27.
  • MacKenzie EJ, Rivara FP, Jurkovich GJ, Nathens AB, Egleston BL, Salkever DS, Frey KP, Scharfstein DO. The impact of trauma center care on functional outcomes following major lower limb trauma. J Bone Joint Surg. 2008; 90:101-09.
  • Mason WS, Litwin S, Jilbert AR. Immune selection during chronic hepadnavirus infection. Hepatol Int. 2008;2:3-16.
  • Mastalski K, Coups EJ, Ruth K, Raysor S, Giri VN. Substantial family history of prostate cancer in black men recruited for prostate cancer screening: results from the Prostate Cancer Risk Assessment Program Cancer.2008;113:2559-64.
  • Meropol NJ, Egleston BL, Buzaglo JS, Benson AB, Cegala DJ, Diefenbach MA, Fleisher L, Miller SM. Cancer patient preferences for quality of life. Cancer. 2008;113:3459-66.
  • Paralkar VR, Li T, Langer CJ. Population characteristics and prognostic factors in metastatic non-small cell lung cancer: A Fox Chase Cancer Center retrospective. Clin Lung Cancer. 2008;9:116-21.
  • Psyrri A, Egleston B, Weinberger P, Yu Z, Kowalski D, Sasaki C, Haffty B, Rimm D, Burtness B. Correlates and determinants of nuclear epidermal growth factor receptor content in an oropharyngeal cancer tissue microarray Cancer. Epidemiol Biomarkers Prev. 2008; 6:1486-92.
  • Sharkey RM, Karacay H, Litwin S, Rossi EA, McBride WJ, Chang CH, Goldenberg DM. Improved therapeutic results by pretargeted radioimmunotherapy of non-Hodgkin's lymphoma with a new recombinant trivalent anti-CD20 bispecific antibody. Cancer Res. 2008; 68:5282-90.
  • Shimizu I, Jellinek NJ, Dufresne RG, Li T, Devarajan K, Perlis C. Multiple antithrombotic agents increase the risk of post-operative hemorrhage in dermatologic surgery. J Am Acad Dermatol. 2008; 58:810-16.
  • Singh MK, Dadke D, Nicolas E, Serebriiski IG, Apostolou S, Canutescu A, Egleston BL, Golemis EA. A novel Cas family member HEPL regulates FAK and cell spreading. Mol Biol Cell. 2008; 19:1627-36.
  • Yeung AT, Patel BB, Li XM, Seeholzer SH, Coudry RA, Cooper HS, Bellacosa A, Boman BM, Zhang T, Litwin S, Ross EA, Conrad P, Crowell JA, Kopelovich L, Knudson A. One-hit effects in cancer: Altered proteome of morphologically normal colon crypts in Familial Adenomatous Polyposis .Cancer Res. 2008; 68:7579-86.

2007

  • Buzaglo JS, Millard JL, Ridgway CG, Ross EA, Antaramian SP, Miller SM, Meropol NJ. An internet method to assess cancer patient information needs and enhance doctor-patient communication: A Pilot Study. J Cancer Educ 2007;22:233-40.
  • Chang WC, Coudry RA, Clapper ML, Zhang X, Williams KL, Spittle CS, Li T, Cooper HS. Loss of p53 enhances the induction of colitis-associated neoplasia by dextran sulfate sodium. Carcinogenesis. 2007;28:2375-81.
  • Cordera F, Arciero CA, Li T, Watson JS, Hoffman JP. Significance of common hepatic artery lymph node metastases during pancreaticoduodenectomy for pancreatic head adenocarcinoma. Ann Surg Oncol. 2007;14:2330-36.
  • Egleston BL, Scharfstein DO, Freeman EE, West SK. Causal inference for non-mortality outcomes in the presence of death. Biostatistics. 2007; 8:526-45.
  • Freedman GM, Anderson PR, Goldstein LJ, Ma CM, Li J, Swaby RF, Litwin S, Watkins-Bruner D, Sigurdson ER, Morrow M. Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost. Int J Radiat Oncol Biol Phys .2007;68:347-53.
  • Henry LR, Lee HO, Lee JS, Klein-Szanto A, Watts P, Ross EA, Chen WT, Cheng JD. Clinical implications of fibroblast activation protein in patients with colon cancer. Clin Cancer Res. 2007;13:1736-41.
  • Henry LR, Sigurdson E, Ross EA, Lee JS, Watson JC, Cheng JD, Freedman GM, Konski A, Hoffman JP. Resection of isolated pelvic recurrences after colorectal surgery: long-term results and predictors of improved clinical outcome. Surg Oncol. 2007; 7:2000-09.
  • Hensley H, Quinn BA, Wolf RL, Litwin SL, Mabuchi S, Williams SJ, Williams C, Hamilton TC, Connolly DC. Magnetic resonance imaging for detection and determination of tumor volume in a genetically engineered mouse model of ovarian cancer. Cancer Biol Ther. 2007;6:1717-25.
  • Johnson JE, Gettings EJ, Schwalm J, Peri J, Testa JR, Litwin S, vonMehren M, Broccoli D. Whole-genome profiling in liposarcomas reveals genetic alterations common to specific telomere maintenance mechanisms. Cancer Res. 2007; 67:9221-28.
  • Konski AA, Cheng JD, Goldberg M, Li T, Maurer A, Yu JQ, Haluszka O, Scott W, Meropol NJ, Cohen SJ, Freedman G, Weiner LM. Correlation of molecular response as measured by 18-FDG positron emission tomography with outcome after chemoradiotherapy in patients with esophageal carcinoma. Int J Radiat Oncol Biol Phys. 2007; 69:358-63.
  • Kunkle DA, Crispen PL, Li T, Uzzo RG. Tumor size predicts synchronous metastatic rental cell carcinoma: implications for survelliance of small renal masses. J Urol. 2007;177:1692-96.
  • Langer CJ, Ruth K, Borghaei H, Treat JA, Shafer D, Millenson M, Tuttle H, Rovito M, Mintzer D. Phase II trial of cetuximab (C225) in combination with monthly carboplatin (Cb) and weekly paclitaxel (Pac) in patients with advanced NSCLC: Promising early results. J Thoracic Oncol. 2007;2:S465-S66.
  • Langer CJ, Somer R, Litwin S, Feigenberg S, Movsas B, Maiale C, Sherman E, Millenson M, Nicoloau N, Huang C, Treat J. Phase I study of radical thoracic radiation weekly irinotecan and cisplatin in locally advanced non-small cell lung carcinoma. J Thorac Oncol. 2007; 2:203-09.
  • Litwin S, Wong Y-N, Hudes G. Early stopping designs based on progression free survival at an early time point in the initial cohort. Stat Med. 2007; 26:4400-15.
  • Mabuchi S, Altomare DA, Connolly DC, Klein-Szanto A, Litwin S, Hoelzle MK, Hensley HH, Hamilton TC, Testa JR. RAD001 (Everolimus) delays tumor onset and progression in a transgenic mouse model of ovarian cancer. Cancer Res. 2007; 67:2408-13.
  • MacKenzie EJ, Rivara FP, Jurkovich GJ, Nathens AB, Frey KP, Egleston BL, Salkever DS, Weir S, Scharfstein DO. The national study on costs and outcomes of trauma. J Trauma. 2007; 63:S54-67 discussion S81-86.
  • Mason WS, Litwin S, Xu C, Jilbert AR. Hepatocyte turnover in transient and chronic hepadnavirus infections. J Viral Hepat. 2007;14:22-28.
  • Meropol NJ, Buzaglo JS, Millard J, Damjanov N, Miller SM, Ridgway C, Ross EA, Sprandio JD, Watts P. Barriers to clinical trial participation as perceived by oncologists and patients. Natl Compr Canc Netw. 2007;5:655-64.
  • Narra K, Mullins SR, Lee HO, Strzemkowski-Brun B, Magalong K, Christiansen VJ, McKee PA, Egleston B, Cohen SJ, Weiner LM, Meropol NJ, Cheng JD. Phase II yrial of single agent Val-boroPro (Talabostat) inhibiting fibroblast activation protein in patients with metastatic colorectal cancer. Cancer Biol Ther. 2007;6:1691-99.
  • O'Grady MA, Gitelson E, Swaby RF, Goldstein LJ, Sein E, Keeley P, Miller B, Li T, Weinstein A, Cohen SJ. Development and implementation of a medical oncology quality improvement tool for a regional community oncology network: the Fox Chase Cancer Center Partners Initiative. J Natl Compr Cancer Netw. 2007; 5:875-82.
  • O'Sullivan MJ, Freedman G, Li T, Morrow M. The effect of multiple reexcisions on the risk of local recurrence after breast conserving surgery. Ann Surg Oncol. 2007; 14:3133-40.
  • Page RE, Klein-Szanto AJP, Litwin S, Nicolas E, Al-Jumaily R, Alexander P, Godwin AK, Ross EA, Schilder RJ, Bassi DE. Increased expression of the pro-protein convertase furin predicts decreased survival in ovarian cancer. Cell Oncol. 2007; 29:289-99.
  • Patel BB, Li XM, Dixon MP, Blagoi EL, Seeholzer SH, Chen Y, Miller CG, He YA, Tetruashvily M, Chaudhry AH, Ke E, Xie J, Cooper H, Bellacosa A, Clapper ML, Boman BM, Zhang T, Litwin S, Ross E, Conrad P, Crowell JA, Kopelovich L, Knudson A, Yeung AT. Searchable high resolution 2D gel proteome of the human colon crypt. J Proteome Res. 2007;6:2232-38.
  • Patel AA, Gilbertson JR, Showe LC, London JW, Ross E, Ochs MF, Carver J, Lazarus A, Parwani AV, Dhir R, Beck JR, Liebman M, Garcia FU, Prichard J, Wilkerson M, Herberman RB, Becich MJ, the PCABC.  A novel cross-disciplinary multi-institute approach to translational cancer research:  Lessons learned from Pennsylvania Cancer Alliance Bioinformatics Consortium (PCABC).  Cancer Inform. 2007; 3:255-74.
  • Rennefahrt UE, Deacon S, Parker SA, Devarajan K, Beeser A, Chernoff J, Knapp S, Turk BE, Peterson JR. Specificity profiling of Pak kinases allows identification of novel phosphorylation sites. J Biol Chem. 2007; 282:15667-78.
  • Sariya D, Ruth K, Adams-McDonnell R, Cusack C, Zu X, Elenitsas R, Seykora J, Pasha T, Zhang P, Baldassano M, Lessin SR, Wu H. Clinicopathologic correlation of cutaneous metastases: experience from a cancer center. Arch Dermatol. 2007; 143:613-20.
  • Zhou Y, Daryl C, Zou H, Hayes ME, Adams GP, Kirpotin DB, Marks JD. Impact of single-chain fv antibody fragment affinity on nanoparticle targeting of epidermal growth factor receptor-expressing tumor cells. J Mol Biol. 2007; 371:934-47.

2006

  • Ariazi EA, Lewis-Wambi JS, Gill SD, Pyle JR, Ariazi JL, Kim HR, Sharma CGN, Cordera F, Shupp HA, Li T, Jordan VC. Emerging principles for the development of resistance to antihormormonal therapy: Implications for the clinical utility of fulvestrant. J Steroid Biochem Mol Biol. 2006;102:28-138.
  • Berg WA, Weinberg IN, Narayanan D, Lobrano ME, Ross E, Amodei L, Tafra L, Adler LP, Uddo J, Stein W 3rd, Levine EA. Positron Emission Mammography Working Group High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancer. Breast J. 2006;12:309-23.
  • Cai KQ, Klein-Szanto A, Devarajan K, Edelson M, Bergman C, Daly M, Ozols RF, Godwin AK, Hamilton T, Xu X. Age-dependent morphological alterations of human ovaries from populations with and without BRCA mutations Gynecol Oncol. 2006;103:719-28.
  • Chism DB, Freedman GM, Li T, Anderson PR. Re-excision of margins before breast radiation-diagnostic or therapeutic. Int Radiat Oncol Biol Phys. 2006; 65:1416-21.
  • Devarajan K. Nonnegative matrix factorization – A new paradigm for large-scale biological data analysis Proceedings of the Joint Statistical Meetings Seattle Washington August 2006 (CD-ROM) 2007.
  • Freedman GM, Anderson P, Li T, Ross E, Swaby R, Goldstein L. Identifying breast cancer patients most likely to benefit from aromatase inhibitor therapy after adjuvant radiation and tamoxifen. Cancer. 2006;107:2552-58.
  • Langer CJ, Duffy K, Horwitz EM, Litwin S, Rosvold E, Schol J, Keenan E, Nicolaou N, Friedman CD, Ridge JA. Phase I trial of concurrent hyperfractionated split course radiotherapy (HFx RT) cisplatin (cDDP) and paclitaxel in patients with recurrent previously irradiated or treatment-naive locally advanced upper aerodigestive malignancy. Cancer Invest. 2006; 24:164-73.
  • Price RA Jr, Hannoun-Levi JM, Horwitz E, Buyyounouski M, Ruth KJ, Ma CM, Pollack A. Impact of pelvic nodal irradiation with intensity-modulated radiotherapy on treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 2006;66:583-92.
  • Rumfelt L, Zhou Y, Rowley BM, Shinton S, Hardy RR. Lineage specification and plasticity in CD19-negative early B-cell precursors. J Exp Med. 2006; 203:675-87.
  • Summers J, Litwin S. Examining the theory of error catastrophe. J Virol. 2006; 80:20-26.
  • Weaver C, Schiech L, Held-Warmkessel J, Kedziera P, Haney E, DiLullo G, Babb JS, Ruth K, Dell D, Barsevick A. Risk for unplanned hospital readmission of patients with cancer: results of a retrospective medical record review. Oncol Nurs Forum. 2006; 33:E44-52.

2005

  • Altomare DA, Vaslet CA, Skele KL, De Rienzo A, Devarajan K, McClatchey AI, Kane AB, Jhanwar SC, Testa JR. A mouse model recapitulating molecular features of human mesothelioma Priority Report Cancer Res. 2005; 65:8090-95.
  • Bassi DE, Lopez De Cicco R, Cenna J, Litwin S, Cukierman E, Klein-Szanto AJ. PACE4 expression in mouse basal keratinocytes results in basement membrane disruption and acceleration of tumor progression. Cancer Res. 2005;65:7310-19.
  • Cooper HS, Chang WC, Coudry R, Gary MA, Everley L, Spittle CS, Wang H, Litwin S, Clapper ML. Generation of a unique strain of multiple intestinal neoplasia (Apc(+/Min-FCCC)) mice with significantly increased numbers of colorectal adenomas. Mol Carcinog. 2005;44:31-41.
  • Henry LR, Sigurdson E, Ross E, Hoffman J. Hydronephrosis does not preclude curative resection of pelvic recurrences after colorectal surgery .Ann Surg Oncol. 2005;12:786-92.
  • Lewis JS, Meeke K, Csipo C, Ross EA, Kidawi N, Li T, Bell E, Chandel NS, Jordan VC. Intrinsic mechanism of estradiol-indused apoptosia in breast cancer cells resistant to estrogen deprivation. J Natl Cancer Inst. 2005; 97:1746-59.
  • Litwin S, Toll E, Jilbert AR, Mason WS. The competing roles of virus replication and hepatocyte death rates in the emergence of drug-resistant mutants: Theoretical considerations. J Clin Virol. 2005; 35:S96-S107.
  • Nguyen M, Herrine S, Laine C, Ruth K, Weinberg DS. Description of a new Hepatitis C risk assessment tool. Arch Intern Med. 2005; 165:2013-18.
  • Schnoll RA, Wang H, Miller SM, Babb JS, Cornfeld MJ, Higman-Tofani S, Henigan-Peel T, Balshem A, Slater E, Ross E, Boyd CS, Engstrom PF. Change in worksite smoking behavior following cancer risk feedback intervention: A pilot study. Am J Health Behav. 2005; 29:215-27.
  • Tafra L, Cheng Z, Uddo J, Lobrano MB, Stein W, Berg WA, Levine E, Weinberg IN, Narayannan D, Ross E, Beylin D, Yarnall S, Keen R, Sawyer K, Van Geffen J, Freimanis RL, Staab E, Adler LP, Lovelace J, Shen P, Stewart J, Dolinsky S. Pilot clinical trial of 18F-fluorodeoxyglucose positron-emission mammography in the surgical management of breast cancer. Am J Surg. 2005; 190:628-32.